Current Drug Shortages: Bupivacaine Hydrochloride Injection

 The information provided in this section is provided voluntarily by manufacturers.  FDA cannot require firms to report the reason for shortage or duration of the shortage or any other information about shortages.  FDA appreciates all information provided by manufacturers.  We post information about shortages as soon as we receive it from the manufacturers.  To report information about shortages or supply issues, manufacturers can send updates to This e-mail address is being protected from spambots. You need JavaScript enabled to view it .  Healthcare professionals and patients are also encouraged to notify us of shortages at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Acetylcysteine Inhalation Solution (updated 11/10/2011)

Company/ProductsReasonRelated Information
Hospira Inc. Customer Service:
1-877-946-7747

100 mg/mL; 30 mL vial
(NDC 0409-3307-03)
200 mg/mL; 30 mL vial
(NDC 0409-3308-03)

Manufacturing delay.

Product 100 mg/mL; 30 mL vial (NDC 0409-3307-03):  next delivery March 2012.

 

Product 200 mg/mL; 30 mL vial (NDC 0409-3308-03):  next delivery December. 

 

Please check with your wholesaler for available inventory.

Roxane Laboratories
1-614-276-4000

200 mg/mL, 10 mL (NDC 00054-3028-02), 200 mg/mL, 30 mL (NDC 00054-3026-02)

Increase in demand

Roxane Laboratories anticipates releases for emergency shipments in December 2011 for acetylcysteine inhalation solution 100 mg/mL, 10 mL (NDC 00054-3027-02) and 200 mg/mL, 10 mL (NDC 00054-3026-02) vials. Roxane Laboratories anticipates releases for emergency shipments in January 2012 for 100 mg/mL, 30 mL (NDC 00054-3025-02) and 200 mg/mL, 30 mL (NDC 00054-3028-02) vials.

American Regent/Luitpold
631-924-4000

100 mg/mL, 4 mL (NDC 00517-7504-25), 100 mg/mL, 10 mL (NDC 00517-7510-03), 200 mg/mL, 4 mL (NDC 00517-7604-25), 200 mg/mL, 10 mL (NDC 00517-7610-03), 200 mg/mL, 30 mL (NDC 00517-7630-03)

Manufacturing delaysAmerican Regent is releasing acetylcysteine inhalation solution as it becomes available.

 

Alcohol Dehydrated (Ethanol > 98%) (updated 9/22/2011)

Company/ProductsReasonRelated Information
American Regent/Luitpold:
631-924-4000

1 mL ampule, package of 10 (NDC 00517-8571-10); 5 mL ampule, package of 10 (NDC 00517-8575-10)

Manufacturing delays1 ml ampules and 5 ml ampules are now being released.

 

Amikacin Injection (updated 10/25/2011)

CompanyReasonRelated Information

Teva Pharmaceuticals
1-800-545-8800

Manufacturing delaysTeva has amikacin 250 mg/mL 4 mL vials available for drop shipment (NDC 00703-9040-03).
Bedford Customer Service
1-800-562-4797

250 mg/mL, 2 mL vials (NDC 55390-0226-02)
250 mg/mL, 4 mL vials (NDC 55390-0226-04)

Manufacturing delaysBedford has limited allocated quantities of amikacin 250 mg/mL 2 mL (NDC 55390-0226-02) and 1 g/4 mL (NDC 55390-0226-04)  available for drop shipment, contact your local Bedford  Account Executives.

 

Aminocaproic Acid  (updated 11/10/2011)

Company/ProductsReasonRelated Information
Hospira, Inc.
Customer Service: 1-877-946-7747

250 mg/mL; 20 mL vial
(NDC 0409-4345-73)

Other Manufacturer Shortage/Market Withdrawal

Product 250 mg/mL; 20 mL vial (NDC 0409-4346-73):  next delivery November.

Please check with your wholesaler for available inventory.

 


 
American Regent/Luitpold
631-924-4000
Manufacturing delaysAminocaproic Acid Injection, USP 250 mg/mL, 20 mL vial (NDC 00517-9120-25) has been released as of October 4, 2011.

 

Ammonium Chloride Injection (updated 10/31/2011)

Company/ProductsReasonRelated Information

Hospira, Inc.  Customer Service:
1-877-946-7747

5 mEq/mL; 20 mL vial

(NDC 0409-6043-01) 

Other manufacturer shortages/market withdrawal.

Product 5 mEq/mL; 20 mL vial (NDC 0409-6043-01):  company estimates a release date by June 2012.

Please check with your wholesaler for available inventory.

 

Ammonium molybdate injection  (5/19/2011)

Company/ProductsReasonRelated Information

American Regent/Luitpold

631-924-4000

American Regent Molybdenum 25 mcg/mL, 10 mL vial (NDC 00517-6610-25)

Manufacturing delaysAmerican Regent has ammonium molybdate injection on back order and the company cannot estimate a release date.

 

Ammonul (sodium phenylacetate and sodium benzoate) Injection 10%/10% (9/18/2008)

Company/ProductsReasonRelated Information

Ucyclyd Pharma, Inc. 1-888-829-2593, or 1-800-900-6389 with a representative available 24 hours, seven days a week.
phone

See information in Related Information section.

Limited supplies continue to be available.

Please see attached Dear Healthcare Professional Letter (PDF - 66KB) for important safety information.

 

Amphetamine Mixed Salts, ER Capsules  (updated 10/31/2011)

Company/ProductsReasonRelated Information
Shire Customer Service:
1-800-828-2088

Adderall XR capsules
5 mg - 100 count (NDC 54092-0381-01); 10 mg - 100 count (NDC 54092-0383-01); 15 mg - 100 count (NDC 54092-0385-01); 20 mg - 100 count (NDC 54092-0387-01); 25 mg - 100 count (NDC 54092-0389-01); 30 mg - 100 count (NDC 54092-0391-01)

API supply issues and uneven product distribution patterns.Product availability for all dosage strengths is adequate.
Teva Customer Service
(888)838-2872

5 mg - 100 count (NDC 00555-0790-02); 10 mg - 100 count (NDC 00555-0787-02); 15 mg - 100 count (NDC 00555-0791-02); 20 mg - 100 count (NDC 00555-0788-02); 25 mg - 100 count (NDC 00555-0792-02); 30 mg - 100 count (NDC 00555-0789-02)

API supply issuesTeva continue to release product as it becomes available.
Global Customer Service:
(215)558-4300

10 mg ,100 count (NDC 00115-1329-01); 15 mg, 100 count (NDC 00115-1330-01); 20 mg, 100 count (NDC 00115-1331-01); 25 mg, 100 count (NDC 00115-1332-01); 30 mg, 100 count (NDC 00115-1333-01)

Inadequate finished product supply to support current market demandAll finished product strengths are currently available on an allocated basis.

 

Amphetamine Mixed Salts Immediate-Release TabletsNew! (10/28/2011)

Company/ProductsReasonRelated Information
Sandoz Customer Service:
1-609-627-8500

5 mg tablets, 100 count (NDC 00185-0084-01)

10 mg tablets, 100 count (NDC 00185-0111-01)

20 mg tablets, 100 count (NDC 00185-0401-01)

30 mg tablets, 100 count (NDC 00185-0404-01)

Increase in demandReleasing product as it becomes available.
CorePharma
1-800-850-2719

5 mg tablets, 100 count (NDC 64720-0130-10)

10 mg tablets, 100 count (NDC 64720-0132-10)

20 mg tablets, 100 count (NDC 64720-0135-10)

30 mg tablets, 100 count (NDC 64720-0136-10)

Manufacturing delaysCorePharma has all amphetamine mixed salt immediate-release tablets on allocation.
Teva Customer Service:
1-888-838-2872

5 mg tablets, 100 count (NDC 00555-0971-02)

7.5 mg tablets, 100 count (NDC 00555-0775-02)

10 mg tablets, 100 count (NDC 00555-0972-02)

12.5 mg tablets, 100 count (NDC 00555-0776-02)

15 mg tablets, 100 count (NDC 00555-0777-02)

20 mg tablets, 100 count (NDC 00555-0973-02)

30 mg tablets, 100 count (NDC 00555-0974-02)

Adderall, 5 mg tablets, 100 count (NDC 00555-0762-02)

7.5 mg tablets, 100 count (NDC 00555-0763-02)

10 mg tablets, 100 count (NDC 00555-0764-02)

12.5 mg tablets, 100 count (NDC 00555-0765-02)

15 mg tablets, 100 count (NDC 00555-0766-02)

20 mg tablets, 100 count (NDC 00555-0767-02)

30 mg tablets, 100 count (NDC 00555-0764-02)

API supply issuesTeva continue to release product as it becomes available.

 

Anadrol-50 tablets (Oxymetholone Tablets) (8/1/2011)

Company/ProductsReasonRelated Information
Meda Pharmaceuticals Inc.:
732-564-2200

50 mg (bottles of 100) - NDC 68220-055-10

This shortage is due to Active Pharmaceutical Ingredient (API) constraints.Please check with your wholesaler for available inventory. Meda cannot estimate a release date for additional supplies.

 

Aquasol A (updated 9/22/2011)

Company/ProductsReasonRelated Information
Hospira Inc.
1-877-946-7747

50,000 units/mL, 2 mL ampule (NDC 61703-418-07)

Change in manufacturing sites.Hospira anticipates next delivery in 1Q 2012.
   
   

 

Avalide (irbesartan and hydrochlorothiazide)Tablets (3/25/2011)

Company/ProductsReasonRelated Information
Bristol-Myers Squibb
1-800-321-1335
Manufacturing delaysPlease see the following link for updated information: Bristol-Myers Squibdisclaimer icon

 

Bleomycin Injection (updated 11/3/2011)

Company/ProductsReasonRelated Information
APP
1-888-386-1300

15 unit vial (NDC 63323-0136-10), 30 unit vial (NDC 63323-0137-20)

Increased demandAPP has Bleomycin 15 units and 30 units presentations on back order. Releases on both presentations are expected in early January 2012.
Teva Pharmaceuticals
1-800-545-8800
Manufacturing delaysTeva-Sicor has available bleomycin 15 unit (NDC 00703-3154-01) vials. They are reviewing orders prior to release.
Bedford
1-800-562-4797

15 unit vial (NDC 55390-0005-01), 30 unit vial (NDC 55390-0006-01)

Product discontinuedBedford currently has all presentations discontinued.
Hospira Inc. Customer Service:
1-877-946-7747

15 unit vial (NDC 61703-0332-18)
30 unit vial (NDC 61703-0323-22)

Other Manufacturer Shortages/Market Withdrawal

Product 15 unit vial (NDC 61703-332-18):  next delivery January.


Product 30 unit vial (NDC 61703-323-22):  next delivery January.


Please check with your wholesaler for available inventory. 

 

Bupivacaine Hydrochloride Injection New!(11/9/2011)

Company/ProductsReasonRelated Information
APP
1-888-386-1300
Increased demandAPP has Sensorcaine (with & without Epinephrine) on intermittent back-order and the company is releasing product as it becomes available.
Hospira, Inc.
Customer Service
1-877-946-7747

0.25%; 30 mL amp
(NDC 0409-1158-01)

0.25%; 10 mL vial
(NDC 0409-1159-01)

0.25%; 30 mL vial
(NDC 0409-1159-02)

0.25%; 50 mL vial
(NDC 0409-1160-01)

0.5%; 10 mL vial
(NDC 0409-1162-01)

0.5%; 30 mL vial
(NDC 0409-1162-02)

0.75%; 30 mL vial
(NDC 0409-1165-02)

0.25% w/epi
1:200,000; 10 mL vial
(NDC 0409-9042-01)

0.25% w/epi
1:200,000; 30 mL vial
(NDC 0409-9042-17)

0.25% w/epi 1:200,000; 50 mL
(NDC 0409-9043-01)

0.5% w/epi 1:200,000;
10 mL vial
(NDC 0409-9045-01)

0.5% w/epi 1:200,000;
30 mL vial
(NDC 0409-9045-17)

0.5% w/epi 1:200,000;
50 mL vial
(NDC 0409-9046-01)

Manufacturing delays

Product 0.25%; 30 mL amp (NDC 0409-1158-01): next delivery December.


Product 0.25%; 10 mL vial (NDC 0409-1159-01): next delivery November.


Product 0.25%; 30 mL vial (NDC 0409-1159-02): next delivery November.


Product 0.25%; 50 mL vial (NDC 0409-1160-01): next delivery December.


Product 0.5%; 10 mL vial (NDC 0409-1162-01): next delivery December.


Product 0.5%; 30 mL vial (NDC 0409-1162-02): next delivery December.


Product 0.75%; 30 mL vial (NDC 0409-1165-02): next delivery December.


Product 0.25% w/epi 1:200,000; 10 mL vial (NDC 0409-9042-01): next delivery January.


Product 0.25% w/epi 1:200,000; 30 mL vial (NDC 0409-9042-17): next delivery November.


Product 0.25% w/epi 1:200,000; 50 mL vial (NDC 0409-9043-01): next delivery March.


Product 0.5% w/epi 1:200,000; 10 mL vial (NDC 0409-9045-01): next delivery March.


Product 0.5% w/epi 1:200,000; 30 mL vial (NDC 0409-9045-17): next delivery November.


Product 0.5% w/epi 1:200,000; 50 mL vial (NDC 0409-9046-01): next delivery November.


Please check with your wholesaler for available inventory.

 

Buprenorphine injection  (10/3/2011)

Company/ProductsReasonRelated Information
Bedford
1-800-562-4797

1 mL vial (NDC 55390-0010-10)

DelaysBedford has buprenorphine injection on back order and the company cannot estimate a release date.
Hospira
1-877-946-7747

1 mL Carpuject syringe (NDC 00409-2012-32

API supply constraints; require FDA approval of a new API supplierHospira is working through FDA to gain approval of the new API supplier in order to resume production.
American Regent
1-800-645-1706

1 mL vial (NDC 00517-0725-05)

DelaysAmerican Regent has buprenorphine injection 0.3 mg/mL 1 mL vials on long term back order and the company cannot estimate a release date.
Reckitt Benckiser
804-379-1090

Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01)

Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01) are availableReckitt Benckiser has Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01) available.

 

Calcitriol 1 mcg/mL Injection  (updated 9/21/2011)

Company/ProductsReasonRelated Information
American Regent, Inc.
1-800-645-1706

1 mL ampule, 25 count (NDC 00517-0132-25)

Increased demandAmerican Regent has calcitriol injection on back order and the company cannot estimate a release date.
APP Pharmaceuticals
1-888-386-1300

1 mL ampule, 50 count (NDC 63323-0731-01

Increase in demandAPP has calcitriol injection on back order and plans releases in early November.
Abbott Laboratories
1-800-255-5162

1 mL ampule, 100 count (NDC 00074-8110-31)

Manufacturing delaysAbbott has Calcijex 1 mcg/mL injection on back order with an estimated release date in October 2011.
West-Ward Pharmaceuticals Customer Service:
1-800-631-2174

1 mL ampule, 5 count (NDC 00143-9728-05)

Contract manufacturer cannot meet USP requirementsWest-Ward has calcitriol injection on back order and the company cannot estimate a release date.

 

Calcium Chloride Injection (updated 10/31/2011)

Company/ProductsReasonRelated Information
Hospira Inc.
1-877-946-7747
Manufacturing delay

Product 100 mg/mL; 10 mL Abboject (NDC 0409-4928-34):  next delivery December.

Product 100 mg/mL; 10 mL Ansyr (NDC 0409-1631-10):  next delivery December.

 

Please check with your wholesaler for available inventory.

American Regent, Inc.
1-800-645-1706
 American Regent, Inc. is not currently releasing Calcium Chloride Injection, USP 100 mg/mL in a 10 mL vial. Information on releases will be posted once available.
Amphastar Pharmaceuticals, Inc./IMS
1--800-423-4136
 Amphastar (IMS) in cooperation with FDA will re-introduce its emergency syringes including Dextrose 50%, Epinephrine 0.1mg/mL, Calcium Chloride 100mg/mL, Sodium Bicarbonate 8.4%, Atropine Sulfate 0.1mg/mL, Lidocaine 2%, and Morphine 1mg/mL. Calcium Chloride 100mg/ml syringes (NDC 0548-3304-00/product code 3304) were released by Amphastar/IMS on 9/7/10 and are now available.

 

Calcium Gluconate (updated 6/24/2011)

Company/ProductsReasonRelated Information
APP
1-888-386-1300

100 mg/mL vials, 10 mL vials (NDC 63323-0311-10)50 mL vials (NDC 63323-0311-50) 100 mL vials (NDC 63323-0311-61)

Increased DemandAPP has calcium gluconate 100 mg/mL - 100 mL (63323-311-61) & 100mg/mL- 50 mL (63323-311-50) vials on intermittent back order due to increased demand and the company is releasing the product as it becomes available. The 100 mg/mL- 10mL (63323-311-10) vials are being allocated.  The 200 mL vials have been discontinued.
Luitpold
631-924-4000

50 mL (NDC 0051703950-25), and 100 ml NDC (00517-3900-25) vials

Increase in demandAmerican Regent has calcium gluconate 100 mg/mL 50 mL and 100 mL vials on back order. The 10 mL vials have been discontinued.

 

Cerezyme (imiglucerase for injection) (9/16/2011)

 

Cisplatin injection 1 mg/mL solution (updated 5/10/2011)

Company/ProductsReasonRelated Information
APP
1-888-386-1300
Increased DemandAPP is continuing to allocate as releases occur: 50 mL vial (NDC 63323-0103-51), 100 mL vial (NDC 63323-0103-65) and 200 mL vial (NDC 63323-0103-64).
Teva Pharmaceuticals
1-800-545-8800
Manufacturing delaysTeva continues to release cisplatin injection 1 mg/mL solution. 50 mL vial (NDC 00703-5747-11) and 100 mL vial (NDC 00703-5748-11) as it becomes available.
Bedford
1-800-562-4797
Product discontinuedBedford currently has all presentations discontinued.

 

Cyanocobalamin injection (updated 9/22/2011)

Company/ProductsReasonRelated Information
APP Pharmaceuticals
1-888-386-1300

1000 mcg/mL, 1 mL vial (NDC 63323-0044-01)

Increase in demandAPP has cyanocobalamin injection on intermittent back order and the company is releasing product as it becomes available.
American Regent, Inc.
1-800-645-1706

1000 mcg/mL, 1 mL vial (NDC 00517-0031-25), 1000 mcg/mL, 10 mL vial (NDC 00517-0032-25) 1000 mcg/mL, 30 mL vial (NDC 00517-0130-05)

Manufacturing delaysAmerican Regent has 1ml and 10 ml vials being released the week of September 26th.

 

Daunorubicin hydrochloride solution for injection  (updated 11/3/2011)

Company/ProductsReasonRelated Information
Teva Pharmaceuticals
1-800-545-8800

5 mg/mL, 4 mL single-dose vial (NDC 00703-5233-13)

Manufacturing issuesTeva has daunorubicin solution for injection on back order and estimates a release date of August, 2011.
Bedford Customer Service
1-800-562-4797

5 mg/mL, 4 mL single-dose vial (NDC 55390-0108-10), 10 mL single-dose vial (NDC 55390-0108-01) Cerubidine lyophilized powder for injection, 20 mg single-dose vial, package of 10 (NDC 55390-0281-10)

Manufacturing delaysBedford has short supplies of daunorubicin injection 20 mg/4 mL (NDC 55390-0108-10) and 50 mg/10 mL (NDC 55390-0108-01) contact your local Bedford Account Executive. Bedford Laboratories also has short supplies of Cerubidine (daunorubicin for injection) 20 mg (NDC 55390-0281-10)contact your local Bedford Account Executive.

 

Desmopressin Injection (updated 10/31/2011)

Company/ProductsReasonRelated Information
Ferring
1 888 Ferring
(1-888-337-7464)

4 mcg/mL 1ml vials (NDC 55566-5030-01) and 4mcg/mL 10ml (NDC 55566-5040-01)

n/aFerring is continuing to release product as soon as it becomes available.
Hospira Inc. Customer Service:
1-877-946-7747

4 mcg/mL, 1 mL amp (NDC 00409-2265-01)

Manufacturing delay

Product 4 mcg/mL; 1 mL amp (NDC 0409-2265-01):  next delivery December.

Please check with your wholesaler for available inventory.

 

Sanofi-Aventis
1-800-981-2491

(DDAVP 4 mcg/mL 1 mL (NDC 00075-2451-01) and 10 mL (NDC 00075-2451-53))

Unanticipated increased demandSanofi is continuing to release product as soon as it becomes available.
Teva Pharmaceuticals
1-800-545-8800

(4 mcg/mL, 1 mL vial, 10 count (NDC 00703-5051-03) 10 mL multi-dose vial (NDC 00703-5054-01)).

Manufacturing delaysTeva has available desmopressin 4 mcg/mL 1 mL (NDC 00703-5051-03) and 10 mL (NDC 00703-5054-01) vials and is reviewing orders prior to release.

 

Dexamethasone Injection (updated 7/14/2011)

Company/ProductsReasonRelated Information
American Regent Inc.
(1-800-645-1706)
Manufacturing issuesAmerican Regent has recalled a number of their dexamethasone 4 mg/mL presentations due to the presence of particulate matter. The firm has placed their product on hold with no estimated release date.
APP
(1-888-386-1300)
APP has dexamethasone injection on allocation due to increased demand for the product.APP has all dexamethasone 4mg/mL and 10mg/mL presentations on intermittent back order and the company is releasing the product as it becomes available.  APP will have releases throughout June, July, and August to respond to the increased demand..
West-Ward Pharmaceuticals
Customer Service:
1-888-229-0001
(Formerly a Baxter Product)

1 mL vial
(NDC 0641-0367-25)

Unexpected increase in product demand due to market supply issues.West-Ward is currently experiencing a backorder situation on the 10 mg/mL, 1 mL vial  (NDC 0641-0367-25). West-Ward has accelerated production and will have product available by the middle of July.  Additional lots are scheduled to be released by the end of August.

 

Diazepam InjectionNew! (10/28/2011)

Company/ProductsReasonRelated Information
Hospira, Inc.
Customer Service:
1-877-946-7747

5 mg/mL; 2 mL Carpuject (0409-1273-32)

5 mg/mL; 10 mL vial
(0409-3213-12)

Carpuject: Material shortage.

Vial: Manufacturing delay.

Product 5 mg/mL; 2 mL Carpuject (0409-1273-32): next delivery March 2012.

Product 5 mg/mL; 10 mL vial (0409-3213-12): next delivery March 2012.

 

Digoxin Injection (updated 6/24/2011)

Company/ProductsReasonRelated Information
West-Ward Pharmaceuticals Customer Service:
1-888-229-0001 (Formerly a Baxter Product)

USP 250 mcg/mL, 2 mL ampuls (NDC 0641-1410-35)

Increase in product demandWest-Ward is currently experiencing a back order situation on the 2 mL ampuls (NDC 0641-1410-35) due to unforeseen demand driven by competitors' supply issues.  West-Ward has accelerated production and will have product available by the end of July – beginning of August.
Sandoz Customer Service:
1-609-627-8500

USP 250 mcg/mL, 2 mL (NDC 0781-3059-95)

Manufacturing delaysSandoz anticipates supply in 3Q 2011.
GlaxoSmithKline Customer Service:
888-825-5249

Lanoxin Injection, USP 250 mcg/mL, 2 mL (50s - NDC 00173-0260-35)

Manufacturing delaysGSK has discontinued the manufacturing Lanoxin Injection, USP 250 mcg/mL, 2 mL (50s - NDC 00173-0260-35)

250 mcg/mL, 2 mL (10s - NDC 00173-0260-10) is currently on back-order and should be available January 2012.

 

Diltiazem Injection (updated 11/10/2011)

Company/ProductsReasonRelated Information
Baxter Customer Service
1-888-229-0001

5 mL vial (NDC 10019-510-01) 10 mL vial (NDC 10019-510-02)

25 mL vial (NDC 10019-510-04)

Baxter has accelerated production due to an increase in product demand.Baxter is experiencing a back order situation on all codes and estimates the following product availability:

5 mL vial (NDC 10019-510-01) Additional product releases expected later this month and at the end of May.

10 mL vial (NDC 10019-510-02) - Product will be available end of May

25 mL vial (NDC 10019-510-04) - Product releases expected by mid April and end of May.

Product will be made available as it is released.

Hospira Customer Service
(1-877-946-7747)

5 mg/mL, 5 mL vials (NDC 00409-1171-01); 5 mg/mL, 10 mL vials (NDC 00409-1171-02)

100 mg/mL, ADD-Vantage vials (NDC 00409-4350-03)

Higher than anticipated market demand.

 

Product 5 mg/mL; 5 mL vial (NDC 0409-1171-01):  next deliver December. 

 

Products 100 mg/mL; ADD-Vantage vial (NDC 0409-4350-03) and 5 mg/mL; 10 mL vial (NDC 0409-1171-02):  ample levels of inventory to support market demand.


Please check with your wholesaler for available inventory.

Bedford Customer Service
1-800-562-4797

5 mg/mL 5 mL vials (NDC 55390-0565-05), 5 mg/mL 10 mL vials (NDC 55390-0565-10)

5 mg/mL 25 mL vials (NDC 55390-0565-30), 5 mg/mL 5 mL Novaplus vials (NDC 55390-0566-05)

5 mg/mL 10 mL Novaplus vials (NDC 55390-0566-10), 5 mg/mL 25 mL Novaplus vials (NDC 55390-0566-30)

Manufacturing delaysBedford has available 50 mg/10 mL (NDC 55390-0565-10). Short supply available of 125 mg/25 mL (NDC 55390-0565-30) contact your local Bedford Account Executive.  All other 5 mg/mL injectable products are on back order and the company cannot estimate a release date.

 

Doxorubicin (adriamycin) lyophilized powder (updated 11/10/2011)

Company/ProductsReasonRelated Information
Bedford

10 mg vials (NDC 55390-0231-01)

20 mg vials (NDC 55390-0232-10)

50 mg vial (NDC 55390-0233-01)

Manufacturing delaysBedford has 10 mg (NDC 55390-0231-10), 20 mg (NDC 55390-0232-10) and 50mg (NDC 55390-0233-01) on back order and the company cannot estimate a release date.

 

Doxorubicin Liposomal (Doxil) Injection (updated 10/28/2011)

Company/ProductsReasonRelated Information
Janssen Products, LP (formerly Centocor Ortho Biotech Products, L.P.)-1-800-526-7736 (1-800-JANSSEN)

2 mg/mL, 10 mL (NDC 17314-9600-01); 25 ml (NDC 17314-9600-02)

Manufacturing delays

Estimated Availability 3rd Quarter, 2011.

Janssen Biotech, Inc. has announced an allocation process for physicians to obtain Doxil supply. This information will be available on both the company website and that of its DOXIL Brand.

Please see http://www.doxil.com/sites/default/files/DHCP_september2011.pdf disclaimer icon for additional information.


Important Updates on DOXIL Supply Shortage disclaimer icon

 

Doxorubicin Solution for Injection (updated 11/10/2011)

Company/ProductsReasonRelated Information
APP
1-888-386-1300
APP Product Availability Informationdisclaimer icon
Increased demandAPP is releasing the 2mg/ml 100 ml vials (NDC 63323-0101-61), the 2mg/ml 25 ml vials (NDC 63323-0883-30), and the 2mg/ml 5 ml vials (NDC 63323-0883-05) as it becomes available.
Teva Pharmaceuticals
1-800-545-8800
Manufacturing delaysTeva is releasing all strengths on allocation: Doxorubicin solution for injection, 2 mg/mL 5 mL vial (NDC 00703-5043-03) 25 mL vial (NDC 00703-5046-01) 100 mL vial (NDC 00703-5040-01).
Bedford
1-800-562-4797
Manufacturing delaysBedford has limited allocated quantities available of 50 mg/25 mL injection (NDC 55390-0237-01)and short supplies of 200 mg/100 mL (NDC 55390-0238-01), 10 mg/5 mL (NDC 55390-235-10 and 20 mg/10 mL (NDC 55390-236-10). Contact your local Bedford Account Executive.  All other presentations are on backorder and the company cannot estimate a release date.
Pfizer Injectables
1-800-533-4535
http://www.pfizerinjectables.com/disclaimer icon
Pfizer has product availablePfizer Injectables has available vials of 10mg/5mL (NDC 0069-3030-20), 20mg/10mL (NDC 0069-3031-20), 50mg/25mL (NDC 0069-3032-20), 150mg/75mL (NDC 0069-3033-20), 200mg/100mL (NDC 0069-3034-20).

 

Ethiodol (ETHIODIZED OIL) ampules (12/10/2010)

Company/ProductsReasonRelated Information
Guerbet LLC
Customer Service
(1-877-729-6679)
Product has been discontinued by Nycomed US Inc.Guerbet has acquired the Ethiodol NDA from Nycomed US Inc. effective May 7, 2010 and is working with FDA to resume manufacturing of Ethiodol in the near future to ensure continued availability for the US patients. During this interim period, Guerbet, in conjunction with the FDA, is initiating a temporary importation of LIPIODOL ULTRA-FLUIDE, ethyl esters of iodized fatty acids of poppy seed oil, to the United States market.

See Dear Healthcare Professional Letter (PDF - 588KB) for additional information.
(Letter updated 12/10/2010)

 

Etoposide solution for injection (updated 11/3/2011)

Company/ProductsReasonRelated Information
Bedford
1-800-562-4797
Increased demandBedford has short supplies of 500 mg/25 mL (NDC 55390-0292-01) and 1 gram/50 mL (NDC 55390-0293-01)contact your local Bedford Account Executive. All other etoposide 20 mg/mL presentations are on back order and the company cannot estimate a release date.
Teva Pharmaceuticals
1-800-545-8800
Manufacturing delaysTeva has Toposar 20 mg/mL solution for injection 5 mL (NDC 00703-5653-01)   25 mL and 50 mL vials on back order - Teva is working on having additional supplies as soon as possible.
APP
1-888-386-1300
Manufacturing delaysAPP is releasing all etoposide solution for injection 20 mg/mL presentations as they become available.
BMS Customer Service
1-800-426-7644
Increased demandBMS has available Etopophos 100 mg powder for injection (NDC 00015-3404-20).
Accord Healthcare
919-941-7879

20mg/5mL, 100mg vial (NDC#16729-114-31)

N/AAccord healthcare has product available.

 

Fabrazyme (agalsidase beta) (updated 9/7/2011)

 

Fentanyl Citrate Injection  (updated 11/10/2011)

Company/ProductsReasonRelated Information
Hospira, Inc.
Customer Service:
1-877-946-7747

0.05 mg/mL; 2 mL Carpuject
(0409-1276-32)

0.05 mg/mL; 2 mL amp
(0409-9093-32)

0.05 mg/mL; 5 mL amp
(0409-9093-35)

0.05 mg/mL; 20 mL amp
(0409-9093-38)

0.05 mg/mL; 2 mL vial
(0409-9094-22)

0.05 mg/mL; 5 mL vial
(0409-9094-25)

0.05 mg/mL; 10 mL vial
(0409-9094-28)

0.05 mg/mL; 20 mL vial
(0409-9094-31)

0.05 mg/mL; 50 mL vial
(0409-9094-61)

Manufacturing delay

Product 0.05 mg/mL; 2 mL amp (0409-9093-32):  next anticipated delivery April 2012.


Product 0.05 mg/mL; 5 mL amp (0409-9093-35):  next anticipated delivery December.


Product 0.05 mg/mL; 20 mL amp (0409-9093-38):  next anticipated delivery November.


Product 0.05 mg/mL; 2 mL vial (0409-9094-22):  next anticipated delivery January 2012.


Product 0.05 mg/mL; 5 mL vial (0409-9094-25):  next anticipated delivery January 2012.


Product 0.05 mg/mL; 10 mL vial (0409-9094-28):  next anticipated delivery December.


Product 0.05 mg/mL; 20 mL vial (0409-9094-31):  next anticipated delivery January 2012.


Product 0.05 mg/mL; 50 mL vial (0409-9094-61):  next anticipated delivery December.


Fentanyl products listed above must be ordered through the wholesaler; check with your wholesaler regarding product allocation.  It is recommended that the user institute fentanyl sparing strategies.

________

Product 0.05 mg/mL; 2 mL Carpuject (0409-1276-32):  next delivery November.

 

Carpuject orders (NDC 0409-1276-32) may be placed direct or through the wholesaler, and will be filled in the order in which received.

Dear Healthcare Professional Letter (PDF - 103KB)

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
(Formerly a Baxter Product)

50 mcg/mL

2 mL ampul
(NDC 10019-038-67)

5 mL ampul
(NDC 10019-033-72)

20 mL ampul
(NDC 10019-035-74)

2 mL vial
(NDC 10019-037-27)

5 mL vial
(NDC 10019-037-30)

20 mL vial
(NDC 10019-037-25)

50 mL vial
(NDC 10019-037-83)

Increase in product demand

West-Ward is currently experiencing a backorder situation on all presentations due to unforeseen demand driven by competitor supply issues. West-Ward has accelerated production and will have the following products available.

Lots of the 2 mL, 5 mL, and 20 mL ampul products will be released and available in November 2011.

Additional lots of the 2 mL, 5 mL, 20 mL, and 50 mL vials are scheduled to be manufactured and available in the November – December 2011 timeframe.

Product will be made available as it is released.

 

Fluorouracil Injection (8/17/2011)

Company/ProductsReasonRelated Information
Mylan Institutional
1-888-258-4199
Increased demandMylan Institutional (formerly Bioniche Pharma) has fluorouracil injection 50 mg/mL vials on intermittent back order and the company is releasing allocated product as it becomes available. It is only available for drop shipment orders through wholesalers at this time.
Teva Pharmaceuticals
1-800-545-8800
Manufacturing delaysTeva has all fluorouracil injection presentations on back order and the company estimates a release date of 4th quarter, 2011.
APP
1-888-386-1300
Increased demandAPP has fluorouracil injection 50mg/mL 20mL vials on intermittent back order and the company is releasing product as it becomes available.

 

Foscarnet Sodium Injection (updated 9/16/2011)

Company/ProductsReasonRelated Information
Hospira, Inc.
Customer Service
1-877-946-7747

24 mg/mL; 250 mL bottle
(NDC 0409-3863-02)

24 mg/mL; 500 mL bottle
(NDC 0409-3863-05)

Manufacturing delaysHospira is working to resolve the manufacturng delay and additional information on availability will be forthcoming.
Clinigen Healthcare Please see attached Dear Healthcare Professional Letter (PDF - 519KB) for updated information regarding distribution.

 

Fosphenytoin Sodium Injection (updated 10/3/2011)

Company/ProductsReasonRelated Information
Bedford Laboratories
1-800-562-4797
Not currently marketedProduct Discontinued: Bedford currently has all presentations discontinued.
Hospira
Customer Service:
1-877-946-7747

75 mg/mL; 2 mL vial
(NDC 0409-4857-02)

75 mg/mL; 50 mL vial
(NDC 0409-4857-10)

Manufacturing delayBoth presentations are temporarily discontinued.
Akorn Pharmaceuticals
1-800-932-5676
Not currently marketedAkorn will be off the market for an period of time.
APP
1-888-386-1300
Increase in demandAPP continues to release product as it becomes available.
West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
Increase in demandWest-Ward has available NDC# 0143-9788-25 fosphenytoin 150 mg/2ml and NDC# 0143-9782-10 fosphenytoin 750 mg/10 ml.
American Regent, Inc.
1-800-645-1706
Newly launched productAmerican Regent reports availability of fosphenytoin 75 mg/mL in 2 ml vials (NDC 00517-6902-25).

 

Furosemide Injection (updated 10/20/2011)

Company/ProductsReasonRelated Information
Hospira Inc. Customer Service:
1-877-946-7747

10 mg/mL; 4 mL Ansyr syringe
(NDC 0409-9631-04)

10 mg/mL; 10 mL Ansyr syringe
(NDC 0409-1639-10)

10 mg/mL; 2 mL vial
(NDC 0409-6102-02 )

10 mg/mL; 4 mL vial
(NDC 0409-6102-04)

10 mg/mL; 10 mL vial
(NDC 0409-6102-10)

Manufacturing delay

Product 10 mg/mL; 10 mL Ansyr Syringe (NDC 0409-1639-10):  next delivery in December.

All other presentations:  ample levels of inventory to support market demand.

Please check with your wholesaler for available inventory.

 

 

American Regent, Inc.
1-800-645-1706
Increase in demandAmerican Regent, Inc., the distributor of Furosemide Injection, USP 10 mg/mL manufactured by Luitpold Pharmaceuticals, Inc., will continue to notify its wholesalers of the product release dates for all three presentations of Furosemide Injection, USP 10 mg/mL (2 mL vial, 4 mL in a 5 mL vial and 10 mL vial) so they can communicate product availability and appropriately allocate to the end use.
APP
1-888-386-1300
Increase in demandAPP has available furosemide 10 mg/mL injection 2 mL (NDC 63323-0280-02) and 4 mL (NDC 63323-0280-04) vials.

 

Haloperidol Decanoate Injection (updated 5/10/2011)

Company/ProductsReasonRelated Information
Teva Pharmaceuticals
1-800-545-8800
Manufacturing delaysTeva has all presentations on back order.
Ortho-McNeil Janssen
1-800-526-7736
See Related InformationOrtho-McNeil has Haldol Decanoate available in 50 mg/mL 1 mL ampoules in 3 count (NDC 00045-0253-03) presentations and 100 mg/mL 1 mL ampoules (NDC 00045-0254-14).
APP Pharmaceuticals
1-888-386-1300
See Related InformationAPP has haloperidol decanoate available in 50 mg/mL 5 mL vials (NDC 63323-0469-05). 100 mg/mL 5 mL vials (NDC 63323-0471-05) and 100 mg/mL 1mL vials (NDC 63323-0471-01) and 50 mg/mL 1 mL vials (NDC 63323-0469-01) are being released as they become available.
Bedford Laboratories
Customer Service
1-800-562-4797
Product discontinuedBedford has all presentations of the Haloperidol Decanoate discontinued.

 

Insulin glulisine [rDNA origin] injection) solution for injection (Apidra SoloStar)
 (10/19/2011)

Company/ProductsReasonRelated Information
Sanofi-Aventis
1-800-981-2491
Manufacturing delaysProduct to be available 1st quarter 2012. Please note Apidra vials are not impacted by this shortage.

Dear Healthcare Professional Letter (PDF - 33KB)

 

Intravenous Fat Emulsion (updated 6/3/2011)

Company/ProductsReasonRelated Information
Hospira Inc. Customer Service:
1-877-946-7747

Liposyn III (fatemulsion/soybean oil)

10%; 250 mL (NDC 0409-9790-02)

10%; 500 mL (NDC 0409-9790-03)

20%; 250 mL (NDC 0409-9791-02)

20%; 500 mL (NDC 0409-9791-03)

30%; 500 mL (NDC 0409-6892-03)

Manufacturing delayProducts 10%; 250 mL (NDC 0409-9790-02), 10%; 500 mL (NDC 0409-9790-03), 20%; 250 mL (NDC 00409-9791-02), 20%; 500 mL (NDC 00409-9791-03) and 30%; 500 mL (NDC 00409-6892-03):  Hospira is working with FDA to address the issues that led to the shortage.
Baxter (Intralipid Emulsion)
Customer Service:
(1-888-229-0001)
Baxter now has adequate supply available to meet demand.Baxter has the following Intralipid emulsions available through normal distribution:
20% 100 mL (NDC 00338-0519-48) 20% 250 mL (NDC 00338-0519-02) 20% 500 mL (NDC 00338-0519-03) 20% 1000 mL (NDC 00338-0519-04) 30% 500 mL (NDC 00338-0520-03)

 

Isoniazid Tablets (9/16/2011)

Company/ProductsReasonRelated Information
West-Ward Pharmaceuticals
Customer Service:
1-888-229-0001

(300 mg - 30s - 00143-1261-30, 100s - 00143-1261-01, 1000s - 00143-1261-10; 100mg - 100s - 00143-1260-01, 1000s - 00143-1260-10)

Increase demandReleases planned for September and November
Teva Customer Service:
(888)838-2872

(300 mg - 30s - 00555-0071-01, 100s - 00555-0071-02, 1000s - 00555-0071-05; 100mg - 100s - 00555-0066-02, 1000s - 00555-0066-05)

Delayed releaseReleases planned for September for 300 mg product, 100 mg product continues to be in supply.
Sandoz Customer Service:
1-609-627-8500

(300 mg - 30s - 00185-4350-30, 100s - 00185-4350-01, 1000s - 00185-4350-10; 100mg - 30s - 00185-4351-30, 100s - 00185-4351-01, 1000s - 00185-4351-10)

 Information pending
VersaPharm Service:
1-800-548-0700

(300 mg - 30s - 61748-0013-30, 100s - 61748-0013-01, 1000s - 61748-0013-10; 100mg - 100s - 61748-0016-01)

 Information pending
 

 

Labetalol Hydrochloride Injection (11/10/2011)

Company/ProductsReasonRelated Information

Bedford Customer Service
1-800-562-4797
Labetalol injection 5 mg/mL,
20 mL vials (NDC 55390-0130-20)
40 mL vials (NDC 55390-0130-40)
 

Manufacturing delays

Bedford has 100 mg/20 mL (NDC 55390-0130-20)and 200 mg/40 mL (55390-0130-40)  on backorder and the company cannot estimate a release date.
 
Akorn Customer Service 1-800-932-5676
Labetalol injection 5 mg/mL
20 mL vials (NDC 17478-0420-20)
40 mL vials (NDC 17478-0420-40)
Increased demandAkorn is releasing product as it becomes available and has increased production to meet current increased demand.
 
Hospira, Inc. Customer Service: 1-877-946-7747
5 mg/mL; 20 mL vial
(0409-2267-20)
5 mg/mL; 40 mL vial
(0409-2267-54)
5 mg/mL; 4 mL syringe
(0409-2339-34)
Higher than anticipated market demand

All presentations:  October delivery rec’d; next delivery November.
 

Please check with your wholesaler for all available inventory.


 
Sagent pharmaceuticals, Inc. 866-625-1618
20 mL vials (NDC 25021-0300-20)
40 mL vials (NDC 25021-0300-40)
Increased demand

Additional supplies are expected to be released in November.


 

 

L-cysteine hydrochloride  (10/18/2011)

Company/ProductsReasonRelated Information

American Regent/Luitpold
631-924-4000

50 mg/mL
10 mL vial (NDC 00517-2050-05) 50 mL vial (NDC 00517-2064-25)

Manufacturing delays

American Regent has L-cysteine hydrochloride injection on back order and the company cannot estimate a release date.
Sandoz Customer Service:
1-609-627-8500

50 mg/mL
10 mL vial (NDC 66758-0004-02)
50 mL vial (NDC 66758-0005-02)

Increased demandSandoz has L-cysteine hydrochloride injection 50 mL and 10 mL vials on back order and the company estimates a release date of end of November, 2011.

 

Leucovorin Calcium Lyophilized Powder for Injection (updated 10/3/2011)

Company/ProductsReasonRelated Information
Bedford Laboratories
Customer Service
1-800-562-4797
Manufacturing delaysBedford  has limited allocated quantities available of powder for injection 50 mg (NDC 55390-0051-10), 100 mg (NDC 55390-0052-10), 200 mg (NDC 55390-0053-10), and 350 mg vials(NDC 55390-0054-10).  Bedford  also has limited allocated quantities available of 10 mg/mL, 50 mL injection (NDC 55390-0009-01). Contact your local Bedford Account Executives.
Teva Pharmaceuticals
1-800-545-8800
Manufacturing delaysTeva, in conjunction with the FDA, is initiating a temporary importation of Leucovorin Calcium Folinate Solution for Injection, to the United States market to address the current shortage.
See Dear Healthcare Professional letter (PDF 692KB) for additional information.
APP Pharmaceuticals
1-888-386-1300
APP has recently launched their leucovorin injection in response to the ongoing shortage.APP is currently back-ordered. Initial supplies are limited, however APP is continuing to produce and release leucovorin calcium lyophilized powder for injection (NDC# 63323-710-50 for the 200mg SDV and NDC# 63323-711-00 for the 500mg SDV).

 

Leuprolide Injection  (updated 7/19/2011)

Company/ProductsReasonRelated Information
Teva
1-800-545-8800

1 mg/0.2 ml (NDC 00703-4014-18)

Manufacturing delaysCurrently on backorder, anticipate release is Q411.
Sandoz
1-609-627-8500

1 mg/0.2 ml (NDC 00185-7400-85)

Increase in demandOn intermittent backorder, anticipate release October 2011.
Caraco
313-871-8400

1 mg/0.2 ml (NDC 41616-0936-40)

Increase in demandOn intermittent backorder.

 

Levaquin Injection  (updated 11/1/2011)

Company/ProductsReasonRelated Information

Janssen Pharmaceuticals, Inc.:
1-800-Janssen (1-800-526-7736)

 

Levaquin Injection

250 mg in 50 mL Dextrose 5%, premix bag (NDC 50458-0167-01)
500 mg in 100 mL Dextrose 5%, premix bag (NDC 50458-0168-01)
750 mg in 150 mL Dextrose 5%, premix bag (NDC 50458-0166-01)

Changes in forecasted demandJanssen Pharmaceuticals, Inc. is experiencing intermittent back orders on the following Pre-mixed IV bag presentations of Levaquin due to unexpected changes in forecasted demand. They continue to supply product as it becomes available.

 

Levofloxacin Injection  (updated 11/3/2011)

Company/ProductsReasonRelated Information
Akorn Pharmaceuticals
1-800-932-5676

25 mg/mL, 20 mL vial (NDC 17478-0107-20)

25 mg/mL, 30 mL vial (NDC 17478-0107-30)

Increased DemandAkorn has levofloxacin 25 mg/mL 20 mL and 30 mL vials on intermittent back order and the company is releasing product as it becomes available.
Sagent pharmaceuticals, Inc.
1-866-625-1618

250 mg_50 mL Premix Bag NDC 25021-132-81

500 mg_100 mL Premix Bag NDC 25021-132-82

750 mg_150 mL Premix Bag NDC 25021-132-83

N/ASagent has all 3 strengths available for contracted customers only.
Sandoz
Customer Service:
1-609-627-8500

250 mg in 50 mL Dextrose 5%, premix bag (NDC 00781-3341-09)

500 mg in 100 mL Dextrose 5%, premix bag (NDC 00781-3342-09)

750 mg in 150 mL Dextrose 5%, premix bag (NDC 00781-3343-09)

Manufacturing delaysSandoz has all levofloxacin presentations on back order and releasing product as it becomes available.

 

Levoleucovorin (Fusilev) 50 mg single use vials (updated 7/7/2011)

Company/ProductsReasonRelated Information
Spectrum Pharmaceuticals
1-877-387-4538 or 1-877-FUSILEV
 Fusilev (levoleucovorin) for Injection 50 mg vials (NDC 68152-101-00) are available from Spectrum Pharmaceuticals in ample quantities. Based upon the current and anticipated inventory, Spectrum Pharmaceuticals is able to meet all present and future demand. Please call the Company directly at 1-877-387-4538 to obtain Fusilev which is now approved for CRC.

Reminder: There is potential for dosing errors when interchanging leucovorin and levoleucovorin (Fusilev). The dose of levoleucovorin (Fusilev) is one-half the dose of racemic leucovorin injection (e.g., levoleucovorin [Fusilev] 7.5 mg = racemic leucovorin 15 mg).

For more information visit: Spectrum Pharmaceuticals disclaimer icon web site. 

 

Lorazepam Injection (updated 10/31/2011)

Company/ProductsReasonRelated Information
Baxter Customer Service:
1-888-229-0001

2 mg/mL, 1 mL vial (NDC 10019-0102-01), 1 mL Novaplus vial (NDC 10019-0105-01), 10 mL vial (NDC 10019-0102-10)

Baxter has accelerated production due to an increase in product demand.Baxter has available lorazepam 2 mg/mL 1 mL (NDC 10019-0102-01) and 10 mL (NDC 10019-0102-10) vials, 2 mg/mL 1 mL (NDC 10019-0105-01) and 10 mL (NDC 10019-0105-02) Novaplus vials, 4 mg/mL 10 mL (NDC 10019-0103-10) vials, and 4 mg/mL 1 mL (NDC 10019-0106-01) and 10 mL (NDC 10019-0106-02) Novaplus vials. The 4 mg/mL 1 mL vial is on back order with no estimated release date.
Bedford Laboratories Customer Service:
1-800-562-4797

2 mg/mL, 1 mL vial (NDC 55390-0168-10), 10 mL vial (NDC 55390-0170-10)

Not currrently marketed.Product Discontinued: Bedford currently has all presentations discontinued.

Hospira Inc. Customer Service:
1-877-946-7747

2 mg/mL; 1 mL vial
(NDC 00409-6778-02)
2 mg/mL; 10 mL vial
(NDC 0409-6780-02)
2 mg/mL; 1 mL Carpuject syringe
(NDC 0409-1985-30)
2 mg/mL; 1 mL iSecure syringe
(NDC 0409-1985-05)

 
4 mg/mL; 1 mL vial
(NDC 0409-6779-02)
4 mg/mL; 10 mL vial
(NDC 0409-6781-02)
4 mg/mL; 1 mL
Carpuject syringe (NDC 0409-1539-31)  

Higher than anticipated market demand.

Products 2 mg/mL; 10 mL vial (NDC 0409-6780-02) and 2 mg/mL; 1 mL Carpuject syringe (NDC 0409-1985-30):  ample levels of inventory to support market demand.

Product 4 mg/mL; 1 mL vial (NDC 0409-6779-02):  next delivery in March 2012.

Product 4 mg/mL; 10 mL vial (NDC 0409-6781-02):  next delivery in March 2012.
 

Product 2 mg/mL; 1 mL vial (NDC 0409-6778-02):  next delivery in March 2012.

Please note that 4 mg/mL; 1 mL Carpuject syringe (NDC 0409-1539-31) is temporarily unavailable.

 

Please note that 2 mg/mL; 1 mL iSecure prefilled syringe (NDC 0409-1985-05) has been discontinued.

Please check with your wholesaler for available inventory. 

Akorn:
847-279-6100
N/AAkorn has Lorazepam injection available.

 

Magnesium Sulfate Injection (updated 11/2/2011)

Company/ProductsReasonRelated Information
APP
1-888-386-1300

500 mg/mL, 2 mL vial (NDC 63323-0064-02), 500 mg/mL, 10 mL vial (NDC 63323-0064-10), 500 mg/mL, 20 mL vial (NDC 63323-0064-20), 500 mg/mL, 50 mL vial (NDC 63323-0064-50)

APP has magnesium sulfate injection on shortage due to increased demand for the product.APP has all magnesium sulfate 500 mg/mL presentations on intermittent back order and the company is releasing the product as it becomes available.
American Regent/Luitpold
631-924-4000

500 mg/mL, 2 mL vial (NDC 00517-2602-25), 500 mg/mL, 10 mL vial (NDC 00517-2610-25), 500 mg/mL, 50 mL vial (NDC 00517-2650-25)

Manufacturing delaysAmerican Regent has all magnesium sulfate 500 mg/mL presentations on back order and the company cannot estimate a release date.
Hospira, Inc. Customer Service
1-877-946-7747

 

50%; 20 mL vial

(NDC 0409-2168-02)

 

50 %; 10 mL Ansyr syringe

(NDC 0409-1754-10)

 

40 mg/mL-water; 50 mL bag

(NDC 0409-6729-24)

 

40 mg/mL-water; 100 mL bag

(NDC 0409-6729-23)

 

40 mg/mL-water; 500 mL bag

(NDC 0409-6729-03)

 

40 mg/mL-water; 1000 mL bag

(NDC 0409-6729-09)

 

10 mg/mL-dextrose; 100 mL bag

(NDC 0409-6727-23)

 

80 mg/mL-water; 50 mL bag

(NDC 0409-6730-13)

Manufacturing delay

Product 50 %; 20 mL vial (NDC 0409-2168-02):  next delivery November.

Product 50 %; 10 mL Ansyr syringe (NDC 0409-1754-10): next delivery December.

Product 40 mg/mL; 50 mL bag (NDC 0409-6729-24):  next delivery December.

Product 40 mg/mL-water; 100 mL bag (NDC 0409-6729-23):  next delivery December.

Product 40 mg/mL-water; 500 mL bag (NDC 0409-6729-03):  next delivery early 2012.

 

Product 40 mg/mL-water; 1000 mL bag (NDC 0409-6729-09):  next delivery early 2012.

 

Product 10 mg/mL-dextrose; 100 mL bag (NDC 0409-6727-23):  next delivery December.

 

Product 80 mg/mL-water; 50 mL bag (NDC 0409-6730-13):  next delivery December.

   
Please check with your wholesaler for available inventory.

 

Mesna 100 mg/mL InjectionNew! (11/1/2011)

Company/ProductsReasonRelated Information
Sagent Pharmaceticals:
1-866-625-1618

10 mL vials, 1 count (NDC 25021-0201-10)

10 mL vials, 10 count (NDC 25021-0201-11)

Manufacturing delaysThe 10mL 1 count is on allocation. The 10mL 10 count is on allocation expecting product in early November.
APP:
1-888-386-1300

10 mL vial, 1 count (NDC 63323-0773-11)

10 mL vial, 10 count (NDC 63323-0773-10)

Increased in demandNDC 63323-0773-10 - On allocation until Mid-November and NDC 63323-0773-11 - Available for shipping.
Bedford:
1-800-562-4797

10 mL vial, 1 count (NDC 55390-0045-01)

Manufacturing delaysBedford has mesna injection (NDC 55390-0045-01) on back order and the company cannot estimate a release date.
Teva:
1-800-545-8800

10 mL vial, 10 count (NDC 00703-4805-03)

Manufacturing delaysAnticipating release of product Q212/Q312.
Baxter Customer Service:
1-800-ANA-DRUG
(1-800-262-3784)

10 mL vial, 1 count (NDC 10019-0953-01)

10 mL vial, 10 count (NDC 10019-0953-02)

Mesnex 100 mg/mL Injection,
10 mL vial, 1 count (NDC 00338-1305-01)

10 mL vial, 10 count (NDC 00338-1305-03

Increase in demandSeveral releases planned for November and December.

 

Methylphenidate HCl (updated 11/7/2011)

Company/ProductsReasonRelated Information
Sandoz Customer Service:
1-609-627-8500

5 mg (100s - NDC 00781-8840-01 & 00781-5748-01; 1000s - NDC 00781-8840-10), 10 mg (100s - NDC 00781-5749-01 & 00781-8841-01; 1000s - NDC 00781-1749-10), 20 mg (100s - NDC 00781-8842-01 & 00781-5753-01; 1000s - NDC 00781-1753-10)

20 mg (100s - NDC 00781-8843-01 & 00781-5754-01)

Capacity constraints and receiving API orders.Expect sporadic backorders for the next couple of months.
Mallinckrodt Customer Service:
(800) 325-8888

5 mg (100s - NDC 00406-1121-01; 1000s - NDC 00406-1121-10), 10 mg (100s - NDC 00406-1122-01; 1000s - NDC 00406-1122-10), 20 mg (100s - NDC 00406-1124-01; 1000s - NDC 00406-1124-10) Methylin ER, 10 mg (100s - NDC 00406-1423-01) and 20 mg (100s - NDC 00406-1451-01)

Increased demand combined with unavailable raw material.Very limited supply of most strengths of methylphenidate IR and ER tablets is available. Timing for a return to full supply is indefinite and may be extended.
UCB Customer Service:
1-800-477-7877

5 mg (100s - NDC 53014-0531-07), 10 mg (100s - NDC 53014-0530-07), and 20 mg (100s - NDC 53014-0532-07)

Metadate ER Tablets, 20 mg (100s - NDC 53014-0594-07)

Metadate CD, 10 mg (100s - NDC 53014-0579-07), 20 mg (100s - NDC 53014-0580-07), 30 mg (100s - NDC 53014-0581-07), 40 mg (100s - NDC 53014-0582-07), 50 mg (100s - NDC 53014-0583-07), and 60 mg (100s - NDC 53014-0584-07)

Increased demandUCB is currently in stock in all strengths and presentations of our methylphenidate  CD, ER, and IR product.
Watson Customer Service:
(973) 355-8300

5 mg (100s - NDC 00591-5882-01), 10 mg (100s - NDC 00591-5883-01), and 20 mg (100s - NDC 00591-5884-01)

n/aWatson has all 3 strengths available for contracted customers only.

Noven Customer Service:
866.663.2539 

Daytrana (Methylphenidate Transdermal System)


10 mg (30s - NDC 68968-5552-3) 

15 mg (30s - NDC 68968-5553-3) 

20 mg (30s - NDC 68968-5554-3) 

30 mg (30s - NDC 68968-5555-3)

Not applicable

Currently all product is available

 

Metoclopramide injection (updated 10/20/2011)

Company/ProductsReasonRelated Information
Baxter Customer Service:
(1-888-229-0001)

5 mg/mL, 2 mL vial, 25 count (NDC 10019-0450-02)

Increased DemandBaxter is currently experiencing an increase in demand for metoclopramide injection 5 mg/mL, 2 mL vials (NDC 10019-0450-02). Lots are currently being manufactured and will be release for distribution as product becomes available.
Hospira Inc. Customer Service:
1-877-946-7747

5 mg/mL 2 mL vials (NDC 00409-3414-01)

Available

Product 5 mg/mL; 2 mL vial (NDC 0409-3414-01):  ample levels of inventory to support market demand.

Hospira discontinued Metoclopramide Carpuject syringes in May, 2009 and ampules in February, 2010.

Please check with your wholesaler for available inventory.

Teva Pharmaceuticals
1-800-545-8800

5 mg/mL, 2 mL vial, 25 count (NDC 00703-4502-04)

 Teva has made a business decision to discontinue this product. See the Dear Valued Customer Letter (PDF - 32KB)

 

Mexiletine Capsules (150mg, 200mg, and 250mg) (9/24/2010)

Company/ProductsReasonRelated Information
Teva Pharmaceuticals
1-800-545-8800
Manufacturing DelaysTeva has mexiletine 150 mg capsules (NDC 00093-8793-01) and 250 mg capsules (NDC 00093-8741-01). There is not yet an availability date for the 200 mg capsules.

 

Mitomycin Powder for Injection (11/3/2011)

Company/ProductsReasonRelated Information
Accord Customer Service:
919-941-7879

5 mg (NDC 16729-0115-05, 20 mg (NDC 16729-0108-11), 40 mg (NDC 16729-0116-38)

Increase in demandAccord is releasing batches as they become available and is ramping up production to meet the increase in demand.
Bedford Laboratories:
1-800-562-4797

5 mg (NDC 55390-0251-01), 20 mg (NDC 55390-0252-01), 40 mg (NDC 55390-0253-01)

Manufacturing delaysBedford has limited allocated quantities of 5 mg (NDC 55390-0251-01) and 20 mg (NDC 55390-0252-01) along with a short supply of 40 mg (NDC 55390-0253-01) are available for drop shipment, contact your local Bedford Account Executive.

 

Morphine Sulfate Injection  (updated 11/10/2011)

Company/ProductsReasonRelated Information
Hospira, Inc.
Customer Service:
1-877-946-7747

25 mg/mL; 10 mL vial (0409-1135-02)

4 mg/mL; 1 mL Carpuject (0409-1258-30)

2 mg/mL; 1 mL Carpuject (0409-1762-30)

0.5 mg/mL; 10 mL vial (0409-3814-12)

Manufacturing delay

Product 25 mg/mL; 10 mL vial (NDC 0409-1135-02):  next delivery March 2012.

 

Product 4 mg/mL; 1 mL Carpuject (NDC 0409-1258-30):  next delivery November.

 

Product 2 mg/mL; 1 mL Carpuject (NDC 0409-1762-30):  next delivery November.

 

Product 0.5 mg/mL; 10 mL vial (NDC 0409-3814-12):  next delivery December.

 

Product 1 mg/mL; 10 mL vial (NDC 0409-3815-12):  next delivery December.

 

All other presentations:  ample levels of inventory to support market demand.

 

Please check with your wholesaler for available inventory.

 

 

Mustargen (mechlorethamine HCl) injection (9/30/2010)

Company/ProductsReasonRelated Information
Lundbeck Inc.
Customer service number:
1-888-514-5204
See Related InformationLundbeck is currently working closely with FDA to gain approval of the transfer of production of Mustargen to a new manufacturing site after the company’s previous contractor discontinued commercial manufacturing of the product.

Lundbeck expects Mustargen to be available again during 2011. Updates will be provided as they become available.

Please see the Dear Healthcare Professional Letter (PDF - 24KB) from Lundbeck for additional information.

 

Multi-Vitamin Infusion (Adult and pediatric) (updated 11/10/2011)

Company/ProductsReasonRelated Information
Hospira , Inc.
Customer Service
1-877-946-7747

MVI-12 Adult; 10 mL vial (NDC 61703-423-81)
MVI-12 Adult; 2x50 mL PBP(NDC 61703-423-83)
MVI Adult; 10 mL vial (NDC 61703-422-81) MVI Adult; 2x5 mL (NDC 61703-422-82) MVI Adult 2x50 mL PBP (NDC 61703-422-83)
MVI Pediatric; 5 mL vial (NDC 61703-421-53)

Manufacturing delays

MVI Pediatric 5 mL vial (NDC 61703-421-53):  next delivery November.

 

All Adult formulations:  Hospira is working to restore adequate supply.  The following products are targeted for market return in 2012:

-MVI-12 Adult; 2x50 mL PBP (NDC 61703-423-83)

-MVI Adult; 2x5 mL (NDC 61703-422-82)

-MVI Adult 2x50 mL PBP (NDC 61703-422-83)


 

 

Baxter (Infuvite adult and pediatric IV solution)
Customer Service:
1-888-229-0001
Manufacturing delaysInfuvite is now available for Baxter.

 

Nalbuphine Injection (updated 10/31/2011)

Company/ProductsReasonRelated Information
Hospira
1-877-946-7747

NDC and Product Description:
10 mg/mL; 1 mL amp NDC 0409-1463-01

10 mg/mL; 10 mL vial NDC 0409-1464-01

20 mg/mL; 1 mL amp NDC 0409-1465-01

10 mg/mL; 10 mL vial NDC 0409-1467-01

Other manufacturer shortages/market withdrawal.

Product 20 mg/mL; 1 mL amp (NDC 0409-1465-01): next delivery in March 2012.


Hospira has all other presentations available with ample levels of inventory to support market demand.

Please check with your wholesaler for available inventory.

 

 

 

 

NeoProfen (ibuprofen lysine) Injection (updated 8/1/2011)

Company/ProductsReasonRelated Information
Lundbeck Inc.
Customer service number:
1-888-514-5204
Failure to meet a visible particulate quality specification.Lundbeck voluntarily recalled NeoProfen as a safety precaution. As NeoProfen stock is being replenished by the manufacturer, supply is anticipated to be available by end of 2011.

 

Neostigmine methylsulfate injection (7/19/2011)

Company/ProductsReasonRelated Information
Baxter Customer Service:
(1-888-229-0001)

0.5 mg/mL vials (NDC 10019-0271-10), Baxter 1 mg/mL, 10 mL vial (NDC 10019-0270-10)

Increased demandBaxter has available neostigmine 1 mg/mL, 10 mL vials (NDC 10019-0270-10). The 0.5 mg/mL 10 mL vials are on back order and there is not yet a reported release date.
American Regent/Luitpold
631-924-4000

0.5 mg/mL 10 mL vials (NDC 00517-0034-25) and 1 mg/mL 10 mL vials (NDC 00517-0033-25)

Increased demandAdditional information regarding supplies of 0.5 mg/mL 10 mL vials (NDC 00517-0034-25), 1 mg/mL 10 mL vials (NDC 00517-0033-25) will be posted as soon as it's available.
APP
1-888-386-1300

0.5 mg/mL, 10 mL vial (NDC 63323-0382-10), 1 mg/mL 10 mL vials (NDC 63323-0383-10)

Increased demandAPP has all Neostigmine Injection 0.5mg/mL and 1mg/mL presentations on allocation due to increased demand.

 

Neupro (rotigotine transdermal system) (5/5/2010)

Company/ProductsReasonRelated Information
UCB, Inc
800-477-7877
UCB has recalled all domestic lotsFDA has requested that UCB reformulate Neupro (rotigotine transdermal system) patches. UCB is committed to bringing Neupro to U.S. patients and has already made significant progress in the development of the new formulation.

If you have additional questions about the status of Neupro, or about UCB’s Patient Access program for Neupro, please contact UCB Medical Information at 1-866-822-0068 (option 9).

 

Norepinephrine Bitartrate Injection (updated 11/10/2011)

Company/ProductsReasonRelated Information
Bedford Customer Service:
1-800-562-4797

(Bedford 4 mL vial, package of 10 (NDC 55390-0002-10))

Manufacturing delays

Bedford has norepinephrine 1 mg/mL 4 mL (NDC 55390-0002-10) vials on back order and the company cannot estimate a release date.

Hospira Inc.
1-877-946-7747

1 mg/mL 4 mL ampules (NDC 0409-1443-04) and 4 mL vials (NDC 0409-3375-04)

Available

Levophed (Norepinephrine Bitartrate Injection)

 

Products 1 mg/mL; 4 mL ampule (NDC 0409-1443-04) and 1 mg/mL; 4 mL vial (NDC 0409-3375-04):  ample levels of inventory to support market demand.


Please check with your wholesaler for available inventory. 

Teva Pharmaceuticals
1-800-545-8800

(Teva 4 mL vial, package of 10 (NDC 00703-1153-03))

Teva temporarily discontinued norepinephrine in June 2010.Teva anticipates having product available again 4th quarter 2011.
Sandoz Inc. Sandoz, in conjunction with the FDA, is initiating a temporary importation of Norepinephrine Injection, to the United States market.

Please see the Dear Healthcare Professional Letter (PDF - 296KB) for information about emergency supplies that are now available to help address the shortage.

 

Ontak injection (9/22/2011)

Company/ProductsReasonRelated Information
Eisai
1-888-422-4743

150 mcg/mL, Eisai
2 mL vial (NDC 62856-0603-01)

Manufacturing issueEisai is working to have product available again. For information on Patient Access Program, please visit: http://www.ontak.com/disclaimer icon

 

Oxsoralen (methoxsalen) 1% topical lotion (7/6/2010)

Company/ProductsReasonRelated Information
Valeant Pharmaceuticals International
1-866-819-9007
Manufacturing delaysThere is not yet an estimated release date.

 

Oxsoralen-Ultra (methoxsalen) 10 mg capsules (6/17/2010)

Company/ProductsReasonRelated Information
Valeant Pharmaceuticals International
Customer Service
1-800-556-1937
Manufacturing delaysValeant has released limited quantity of Oxsoralen-Ultra 10mg capsules to the market and is committed to ensuring the product is allocated properly to patients in need. Please see the Dear Healthcare Professional Letter (PDF - 49KB) for additional information.

You may also contact Valeant by e-mail at This e-mail address is being protected from spambots. You need JavaScript enabled to view it for additional information.

 

Paclitaxel Injection  (updated 11/10/2011)

Company/ProductsReasonRelated Information
Sandoz:
1-800-525-8747
6 mg/mL injection

30 mg/5 mL vial (NDC 66578-0043-01) 100 mg/16.7 mL vial (NDC 66578-0043-02) 300 mg/50 mL vial (NDC 66578-0043-03)

Manufacturing delaysSandoz is currently on backorder.
APP
1-888-386-1300
6 mg/mL injection

30 mg/5 mL vial (NDC 63323-0763-05)
100 mg/16.7 mL vial (NDC 63323-0763-16)
300 mg/50 mL vial (NDC 63323-0763-50)

 

Increase in demandAPP is on intermittent back order and is releasing product as it becomes available.
Hospira Inc. Customer Service:
1-877-946-7747

300 mg/50 mL vial (NDC 0409-0342-50)
30 mg/5 mL vial (NDC 0409-0342-09)
100 mg/16.7 mL vial (NDC 0409-0342-22)

Higher than anticipated market demand.

Product 300 mg/50 mL vial (NDC 0409-0342-50):  next delivery November.

Product 30 mg/5 mL vial (NDC 0409-0342-09): next delivery January 2012.

Product 100 mg/16.7 mL vial (NDC 0409-0342-22): next delivery January 2012.

Please check with your wholesaler for available inventory.

 

Bedford Laboratories
1-800-562-4797
6 mg/mL injection

30 mg/5 mL vial (NDC 55390-0114-05)
100 mg/16.7 mL vial (NDC 55390-0114-20)
300 mg/50 mL vial (NDC 55390-0114-50)

Manufacturing delaysBedford has short supplies of 30 mg/5 mL (NDC 55390-0114-05)  available for drop shipment contact your local Bedford Account Executive. All other presentations are on backorder and the company cannot estimate a release date.
Teva
1-800-545-8800
6 mg/mL injection

30 mg/5 mL vial (NDC 00703-4764-01)
100 mg/16.7 mL vial (NDC 00703-4766-01)
150 mg/25 mL vial (NDC 00703-4767-01)
300 mg/50 mL vial (NDC 00703-4768-01)

Manufacturing delaysTeva expecting releases of 16.7 mL, 25 mL, and 50 mL
Sagent Pharmaceticals
1-866-625-1618

30mg/5mL
NDC 25021-213-05

100mg/16.7mL
NDC 25021-213-17

300mg/50mL
NDC 25021-213-50

 Sagent has all 3 products on allocation.

 

Pancuronium Bromide InjectionNew! (11/1/2011)

Company/ProductsReasonRelated Information
Hospira Inc. Customer Service:
1-877-946-7747

1 mg/mL; 10 mL vial
(NDC 0409-4646-01)

Manufacturing delayProducts 1 mg/mL; 10 mL vial (NDC 0409-4646-01): next delivery March 2012.

 

Phenylephrine HCl Injection (updated 7/19/2011)

Company/ProductsReasonRelated Information
West-Ward Pharmaceuticals Customer Service:
1-888-229-0001 (Formerly a Baxter Product)

10 mg/mL, 1 mL (25s - NDC 10019-163-12)

Increase in product demand

West-Ward currently has available inventory.  West-Ward has accelerated production and will have additional lots available for release in July and August.

.
Sandoz Customer Service:
1-609-627-8500

10 mg/mL, 5 mL (25s - NDC 66758-0016-04); 10 mg/mL, 10 mL (1 - NDC 66758-0017-01)

Sandoz is currently on backorder as the current market requirements are more than current inventory due to the shortage in the market.Sandoz anticipates increased product availability by the end of July.
American Regent Customer Service:
1-800-645-1706

10 mg/mL, 1 mL (25s - NDC 00517-0299-25) and 10 mg/mL, 5 mL (25s - NDC 00517-0405-25)

Manufacturing delaysAmerican Regent has available phenylephrine 10 mg/mL 1 mL (NDC 00517-0299-25) and 5 mL (NDC 00517-0405-25) vials.

 

Phytonadione Injectable Emulsion (Vitamin K)New! (11/10/2011)

Company/ProductsReasonRelated Information
Hospira, Inc.
Customer Service:
1-877-946-7747

1 mg/0.5 mL; 0.5 mL amp
(NDC 0409-9157-01)

10 mg/mL; 1 mL amp
(NDC 0409-9158-01)

Manufacturing delay

Product 1 mg/0.5 mL; 0.5 mL amp (NDC 0409-9157-01): next delivery December.

 

Product 10 mg/mL; 1 mL amp (NDC 0409-9158-01): next delivery December.

 

Please check with your wholesaler for available inventory

Amphastar Pharmaceuticals, Inc./IMS
1-800-423-4136

Vitamin K injection, contains polysorbate 80 and propylene glycol

1 mg/0.5 mL, SAF-T-JET prefilled syringe (NDC 00548-1240-00)

1 mg/0.5 mL, MINIJET prefilled syringe (NDC 00548-1140-00)

Amphastar is not experiencing a shortage. This shortage is due to increased demand and Amphastar has increased production to meet demand.Amphastar reports availability. Please note that Vitamin K injection, contains polysorbate 80 and propylene glycol.

 

Primaquine Phosphate Tablets  (10/14/2011)

Company/ProductsReasonRelated Information
Sanofi-aventis U.S. LLC
1-800-633-1610

26.3 mg, 100 count (NDC 0024-1596-01)

Manufacturing issuesSanofi-aventis U.S. is working to restore supply as soon as possible.

 

Potassium Phosphate (updated 6/22/2011)

Company/ProductsReasonRelated Information
Hospira Inc.
(1-877-946-7747)
 Hospira, in agreement with FDA, will return to manufacturing Potassium Phosphate Injection to address the critical shortage so that patient needs continue to be met. Hospira understands the critical necessity of this molecule to the healthcare community and is quickly assessing manufacturing re-start timing and anticipated market recovery dates. At this time an ETA is unavailable.
American Regent American Regent anticipates releasing 3 mMol/mL, 50 mL vial (NDC 00517-2350-25) vials mid-July.

 

Procainamide HCL Injection (updated 10/31/2011)

Company/ProductsReasonRelated Information
Hospira Inc. Customer Service:
1-877-946-7747

100 mg/mL; 10 mL vial

(NDC 0409-1902-01)

500 mg/mL; 2 mL vial

(NDC 0409-1903-01)

Manufacturing delays

Product 500 mg/mL; 2 mL vial (NDC 0409-1903-01):  next delivery in March 2012.

Product 100 mg/mL; 10 mL vial (NDC 0409-1902-01):  ample levels of inventory to support market demand.

Please check with your wholesaler for available inventory.

 

Selenium injectionNew! (10/28/2011)

Company/ProductsReasonRelated Information
American Regent/Luitpold:
631-924-4000

40 mcg/mL, 10 mL vial (NDC 00517-6610-25)

Manufacturing delaysAmerican Regent has selenium injection on back order and the company cannot estimate a release date.

 

Sodium Chloride 23.4% (updated 10/20/2011)

Company/ProductsReasonRelated Information
APP
1-888-386-1300

30 mL vials (NDC 63323-0087-30), 100 mL vials (NDC 63323-0088-61), 200 mL vials (NDC 63323-0088-63)

Increased demandAPP has sodium chloride 23.4% solution for injection on intermittent back order and the company is releasing product as it becomes available.
American Regent, Inc.
1-800-645-1706

30 mL vials (NDC 00517-2930-25), 100 mL vials (NDC 00517-2900-25)

Increased demandAmerican Regent has sodium chloride 23.4% solution 30 mL vials and 100 mL vials are on back order and cannot estimate a release date.
Hospira Inc. Customer Service:
1-877-946-7747

4 mEq/mL; 250 mL bottle (NDC 0409-1130-02)
4 mEq/mL; 100 mL bottle (NDC 0409-1141-02)

Manufacturing delay

Product 4 mEq/mL; 250 mL bottle (NDC 0409-1130-02):  expected availability is TBD.

Product 4 mEq/mL; 100 mL bottle (NDC 0409-1141-02):  expected availability is TBD.

 

 

Sodium Chloride 14.6% Injection (updated 10/20/2011)

Company/ProductsReasonRelated Information
Hospira Inc. Customer Service:
1-877-946-7747

2.5 mEq/mL; 20 mL vial (NDC 0409-6657-73)
2.5 mEq/mL; 40 mL vial (NDC 0409-6660-75)

Available

Products 2.5 mEq/mL; 40 mL vial (NDC 0409-6660-75) and 2.5 mEq/mL; 20 mL vial (NDC 0409-6657-73):  ample levels of inventory to support market demand.

APP
1-888-386-1300

14.6%, 20 mL vials (NDC 63323-0139-20), 40 mL vials (NDC 63323-0139-40)

Increased demandAPP has sodium chloride 14.6% solution for injection 40 mL vials are available. The 20 mL vials are on long-term back order with no estimated release date.

 

Sodium Phosphate Injection (updated 10/6/2011)

Company/ProductsReasonRelated Information
Hospira, Inc. Customer Service:
1-877-946-7747

3 mmol/mL, 15 mL vial (NDC 00409-7391-72)

Manufacturing delay

Product 3 mmol/mL; 15 mL vial (NDC 0409-7391-72):  October delivery received; next delivery November.

American Regent/Luitpold
631-924-4000

5 mmol/mL, 5 mL vial (NDC 00517-3405-25), 5 mmol/mL, 15 mL vial (NDC 00517-3415-25), 5 mmol/mL, 50 mL vial (NDC 00517-3450-25)

Manufacturing delaysAmerican Regent expects mid August release for  sodium phosphate 5 mmol/mL 5 mL (NDC 00517-3405-25), 15 mL (NDC 00517-3415-25), and 50 mL (NDC 00517-3450-25) vials.

 

Streptomycin for Injection, USP (10/25/2011)

Company/ProductsReasonRelated Information
X-Gen Pharmaceuticals
1-607-562-2700 Ext 352
Manufacturing delay

X-Gen plans to have streptomycin injection available by end of October 2011.

 

Sulfamethoxazole 80mg/trimethoprim 16mg/ml injection (SMX/TMP) (8/5/2010)

Company/ProductsReasonRelated Information
Teva Pharmaceuticals
1-800-545-8800
Teva recalled Lot #31308526B/Exp. Date 9/2012 of SMX/TMP Injection 10 ml vials to the retail level because some vials may have defective crimps.Teva manufactures 5 ml vials (NDC 00703-9503-03), 10 ml vials (NDC 00703-9514-03) and 30 ml vials (NDC 00703-9526-01). Limited emergency supplies are available from Teva.

 

Tetracycline Capsules  New! (11/8/2011)

Company/ProductsReasonRelated Information
Teva Pharmaceuticals
1-800-545-8800

250 mg, 100 count (NDC 00172-2416-60)

250 mg, 100 count unit dose (NDC 00172-2416-10)

250 mg, 1000 count (NDC 00172-2416-80)

500 mg, 100 count (NDC 00172-2407-60)

500 mg, 100 count unit dose (00172-2407-10)

500 mg, 1000 count (NDC 00172-2407-80)

Manufacturing delaysTeva has all tetracycline capsules temporarily unavailable and the company cannot estimate a release date.
Watson
Customer Service:
(973) 355-8300

250 mg, 100 count (NDC 00591-2234-01)

250 mg, 1000 count (NDC 00591-2234-10)

500 mg, 100 count (NDC 00591-2235-01)

500 mg, 1000 count (NDC 00591-2235-10)

Manufacturing delaysWatson has all tetracycline capsules temporarily unavailable and the company cannot estimate a release date.

 

Thiotepa for Injection (updated 10/25/2011)

Company/ProductsReasonRelated Information
Bedford Laboratories
Customer Service
1-800-562-4797

15 mg/mL vial (NDC 55390-0030-10)

Manufacturing delaysBedford has thiotepa (NDC 55390-0030-10) on backorder and the company cannot estimate a release date.
Adienne Adienne, in conjunction with the FDA, is initiating a temporary importation of Thiotepa for injection, to the United States market. Please see the Dear Healthcare Professional Letter (PDF - 1MB) for information about emergency supplies that are now available to help address the shortage.

 

Thyrogen (thyrotropin alfa) injection 1.1mg/vial (updated 7/14/2011)

Company/ProductsReasonRelated Information
Genzyme Corporation
1-800-745-4447
Temporary DelaysA limited supply of Thyrogen was released to the U.S. market in June.  Due to unexpected delays in the release of three lots of Thyrogen, a stock-out is expected in July and will persist until these lots are released.  Temporary shipment delays will then continue to occur for the remainder of 2011 and throughout 2012.

 

Thyrolar Tablets (12/31/2009)

Company/ProductsReasonRelated Information
Forest PharmaceuticalsManufacturing delaysForest has not yet reported when Thyrolar will be available.

 

Vasopressin Injection  (updated 10/19/2011)

Company/ProductsReasonRelated Information
American Regent/Luitpold
631-924-4000

20 units/mL Injection, 0.5 mL multi-dose vial, 25 count (NDC 00517-0510-25), 1 mL multi-dose vial, 25 count (NDC 00517-1020-25), 10 mL multi-dose vial, 25 count (NDC 00517-0410-10)

N/AAmerican Regent has all strengths of vasopressin 20 units/mL injection 1 mL multi-dose vials (NDC 00517-1020-25), 10 mL multi-dose vials (NDC 00517-0410-10), 0.5 mL multi-dose vials available for ordering.
JHP

Pitressin 20 units/mL Injection, 1 mL single-dose vial, 25 count (NDC 42023-0117-25)

N/AProduct is no longer on allocation.
APP
1-888-386-1300

20 units/mL Injection, 1 mL single-dose vial, 25 count (NDC 63323-0302-01)

APP has increased production to meet current demandAPP has vasopressin 20 units/mL injection available for shipping. Additional releases expected mid-late October 2011.

 

Vecuronium Injection (updated 11/10/2011)

Company/ProductsReasonRelated Information
Bedford Laboratories
Customer Service
1-800-562-4797
Increase in demandBedford has limited allocated quantities 10 mg (NDC 55390-0037-10)  and 20 mg (NDC 55390-0039-10) available for dropship, contact your local Bedford Account Executive.
Sun Pharmaceutical Industries, Inc.
1-800-818-4555
Increase in demandSun Pharmaceutical Industries (Distributor: Caraco Pharmaceutical Labs, Ltd.) is continuing to release product as it becomes available.

Vecuronium Bromide for Injection 10 mg 10 vials NDC 41616-0931-44

Vecuronium Bromide for Injection 20 mg 10 vials NDC 41616-0932-44

Teva Pharmaceuticals
1-800-545-8800
On manufacturing holdTeva has the 10mg/vial (NDC 00703-2914-03) and 20 mg/vial (NDC 00703-2925-03) on backorder.
Hospira, Inc. Customer Service:
1-877-946-7747

10 mg vial (NDC 0409-1632-01)

20 mg vial (NDC 0409-1634-01)

Temporarily suspended

.

 

Sagent Pharmaceticals
1-866-625-1618

NDC

25021-657-10

10 mg per vial

25021-658-20

20 mg per vial

 

Additional supplies are expected to be released in November.

 

 

Vincristine Sulfate Injection (updated 11/10/2011)

Company/ProductsReasonRelated Information
Hospira Inc. Customer Service: 1-877-946-7747

1 mg/mL; 1 mL vial

(NDC 61703-309-06)
1 mg/mL; 2 mL vial

(NDC 61703-309-16)


 
Higher than anticipated market demand.

Product 1 mg/mL; 1 mL vial (NDC 61703-309-06): ample levels of inventory to support market demand.

Product 1 mg/mL; 2 mL vial (NDC 61703-309-16):  next delivery December.

Please check with your wholesaler for available inventory.  

Teva Pharmaceuticals
1-800-545-8800
 Teva has 1 mg/mL 1 mL vial (NDC 00703-4402-11) and 2 mL vial (NDC 00703-4412-11) now available and is shipping to wholesalers.

 

-

Read more http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm#bupivacaine

Search our Catalog

Login/Register






Items for Quote

Your Quote Request Cart is currently empty.